Vascular health in the cerebral cortex can be measured via the vessels’ ability to constrict or dilate under varying physiological conditions. Measuring vascular reactivity can be useful in the diagnosis and management of neurological conditions associated with cerebral microvascular dysfunction, like dementia, traumatic brain injury (TBI) and even aging1,2,3,4. Additionally, CVR can be used as a predictive and/or pharmacodynamic biomarker for neurological disorders such as Alzheimer's5 or TBI6,7,8,9,10. Well-established imaging methods exist to study CVR in human and animal subjects. A typical method includes functional magnetic resonance imaging (fMRI) in conjunction with an exogenous or endogenous stimulus, such as hypercapnia11, breath holding, or acetazolamide2. Lu et al.12,13 demonstrated that a simple gas delivery system coupled with MRI- Blood Oxygen Level Dependent (MRI-BOLD) imaging generates an accurate whole brain CVR maps.
Disruptions to the cerebral vasculature’s blood flow, volume, and metabolic rate of oxygen produces changes in the tissue concentrations of HbO and HbR. Tissue absorption of light at the near infrared range is sensitive to changes in the concentration of hemoglobin species, such as HbO and HbR. Therefore, measuring backscattered light over time can quantify changes of HbO and HbR concentration in the outermost cortex (approximately 2 cm)15, and can be used to assess temporal hemodynamic variations16 including cerebrovascular reactivity (CVR)17.
In our research paradigm, we employ the fNIRS instrument with continuous wave function. The device is composed of 4 sources and 10 detectors, which create 16 source-detector pairs (see Figure 1). The source-detector pairs are molded together onto a silicone strap that can easily be set over the forehead and held in place with self-adherent wrap. The device measures light intensity at 730 and 850 nm and has an acquisition frequency of 2 Hz. This system was selected because it is patient-friendly, easy to wear, and collects data from the prefrontal cortex, a brain region particularly vulnerable to TBI. Fortunately, most other fNIRS systems are compatible with our CVR acquisition technique, differing only in the cortical regions measured based on the brain area of interest.
While fMRI is considered the gold standard for functional brain imaging, fNIRS technology has unique advantages for assessing CVR in comparison to fMRI. The fNIRS imaging technique provides a high temporal resolution (with a granularity of milliseconds) and can quantify changes in both HbO and HbR concentration, while fMRI only measures changes in HbR18,19,20. Moreover, fNIRS instruments are portable, economical, and easier to operate than fMRI. Finally, fNIRS technology better resolves subject motion, which is necessary given that vascular challenges like hypercapnia are often used in combination with cognitive or physical study tasks21.
In this paper, a hypercapnia challenge, combined with fNIRS technology is presented. We measured CVR values and studied the reproducibility of this method, hoping to offer a reliable alternative to fMRI CVR measures.